The properties of Taurine in supplements
|TBS Ingredient ID (TBSI ID):||IS2A1D40|
|2-Aminoethanesulfonic Acid, L-Taurine, Tauphon|
| PubChem CID: |
U.S. National Library of Medicine (PubChem)
| InChI Key: |
International Chemical Identifier hash (InChIKey) computed from chemical structure using the International Union of Pure and Applied Chemistry (IUPAC) standard
| CAS: |
A proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS)
| EC Number: |
A seven-digit regulatory identifier currently assigned by the European Chemicals Agency (ECHA) known as a European Community (EC) number
Taurine (2-aminoethanesulfonic acid C2H7NO3S). Taurine has been shown to reduce the secretion of apolipoprotein B100 and lipids in HepG2 cells. High concentrations of serum lipids and apolipoprotein B100 (essential structural component of VLDL and LDL) are major risk factors of atherosclerosis and coronary heart disease. Hence, taurine supplementation is possibly beneficial for the prevention of these diseases.
Dietary taurine has a blood cholesterol-lowering effect in young overweight adults. Furthermore, body weight also decreased significantly with taurine supplementation. Taurine has also been shown to help people with congestive heart failure by increasing the force and effectiveness of heart-muscle contractions.
Taurine has an observed safe level of supplemental intake in normal healthy adults at up to 3 g/day. Even so, a study by the European Food Safety Authority found no adverse effects for up to 1,000 mg of taurine per kilogram of body weight per day.